Astragalus
Astragalus botanical products marketed for immune, kidney, or longevity claims. Clinical findings are preparation-specific, and a recent telomere trial tested a multi-ingredient Astragalus-based supplement in only 40 participants rather than Astragalus alone.
Pharmacokinetic model
A route-level PK model for astragalus is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- Herb
- Suggested cadence
- once daily
Research behind this entry
-
A Natural Astragalus-Based Nutritional Supplement Lengthens Telomeres in a Middle-Aged Population: A Randomized, Double-Blind, Placebo-Controlled Study
Six-month trial randomized 40 healthy middle-aged volunteers to a proprietary Astragalus-based multi-ingredient supplement or placebo. Telomere measurements favored the intervention, but the small combination trial…
-
Astragalus species: Insights on its chemical composition toward pharmacological applications
Broad review describes substantial species and constituent diversity plus predominantly experimental pharmacology. It supports product-specific interpretation rather than treating Astragalus as a single drug.
2 published studies referenced in the app, each with a plain-language summary.